Patents by Inventor Véronique Orian-Rousseau

Véronique Orian-Rousseau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD44V6-DERIVED CYCLIC PEPTIDES FOR TREATING CANCERS AND ANGIOGENESIS RELATED DISEASES
    Publication number: 20200283503
    Abstract: The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of cancer and angiogenesis related diseases using cyclic peptides.
    Type: Application
    Filed: May 20, 2020
    Publication date: September 10, 2020
    Inventors: Alexandra MATZKE-OGI, Véronique ORIAN-ROUSSEAU, Uwe HABERKORN, Thomas LINDNER, Walter MIER
  • CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
    Patent number: 10703796
    Abstract: The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of cancer and angiogenesis related diseases using cyclic peptides.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: July 7, 2020
    Assignees: AMCURE GMBH, RUPRECHT-KARLS-UNIVERSITÄT
    Inventors: Alexandra Matzke-Ogi, Véronique Orian-Rousseau, Uwe Haberkorn, Thomas Lindner, Walter Mier
  • CD44V6-DERIVED CYCLIC PEPTIDES FOR TREATING CANCERS AND ANGIOGENESIS RELATED DISEASES
    Publication number: 20170320930
    Abstract: The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of cancer and angiogenesis related diseases using cyclic peptides.
    Type: Application
    Filed: December 7, 2015
    Publication date: November 9, 2017
    Inventors: Alexandra MATZKE-OGI, Véronique ORIAN-ROUSSEAU, Uwe HABERKORN, Thomas LINDNER, Walter MIER
  • CD44v6-derived peptides for treating metastasizing cancer
    Patent number: 9593146
    Abstract: The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of pancreatic cancer.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: March 14, 2017
    Assignee: AMCURE GMBH
    Inventors: Veronique Orian-Rousseau, Alexandra Matzke, Helmut Ponta
  • CD44v6-derived peptides for treating pancreatic cancer
    Patent number: 9586993
    Abstract: Compounds, pharmaceutical compositions and methods for treating different forms of pancreatic cancer.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: March 7, 2017
    Assignee: AMCURE GMBH
    Inventors: Veronique Orian-Rousseau, Alexandra Matzke, Helmut Ponta
  • CD44V6-derived peptides for treating breast cancer
    Patent number: 9586994
    Abstract: The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of breast cancer.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: March 7, 2017
    Assignee: AMCURE GMBH
    Inventors: Veronique Orian-Rousseau, Alexandra Matzke, Helmut Ponta
  • CD44V6-Derived Peptides for Treating Metastasizing Cancer
    Publication number: 20150183826
    Abstract: The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of pancreatic cancer.
    Type: Application
    Filed: November 21, 2013
    Publication date: July 2, 2015
    Applicant: KARLSRUHER INSTITUT FUR TECHNOLOGIE
    Inventors: Veronique Orian-Rousseau, Alexandra Matzke, Helmut Ponta
  • CD44V6-Derived Peptides for Treating Pancreatic Cancer
    Publication number: 20150166607
    Abstract: The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of pancreatic cancer.
    Type: Application
    Filed: November 21, 2013
    Publication date: June 18, 2015
    Applicants: KARLSTUHER INSTITUTE FDOR TECHNOLOGIE, AMCURE GMBh
    Inventors: Veronique Orian-Rousseau, Alexandra Matzke, Helmut Ponta
  • CD44V6 peptides as inhibitors of bacterial infections
    Patent number: 8933017
    Abstract: A method for treatment of infection with Listeria spp., Plasmodium spp., or Shigella spp. includes administering a peptide or a pharmaceutically acceptable salt of the peptide to an individual in need of treatment for the infection.
    Type: Grant
    Filed: November 9, 2012
    Date of Patent: January 13, 2015
    Assignee: Karlsruher Institut fur Technologie
    Inventors: Christian Jung, Véronique Orian-Rousseau, Alexandra Matzke, Helmut Ponta
  • Use of a peptide fragment of CD44v6 in the treatment of ophthalmic diseases
    Patent number: 8883738
    Abstract: The present invention relates to the use of peptide compounds for the prevention and/or treatment of ophthalmic diseases. In particular, the present invention relates to a peptide compound comprising an amino acid sequence displayed by amino acids 7 to 11 of SEQ ID NO: 2 (KEQWFGNRWHEGYR) or of SEQ ID NO: 1 (KEKWFENEWQGKNP), or a functionally active derivative thereof, or a pharmaceutically acceptable salt thereof, for use in the prevention and/or treatmend of an ophthalmic disease in an individual. While SEQ ID NO: 2 is a part of the human CD44v6, SEQ ID NO: 1 is a part of the rat CD44v6.
    Type: Grant
    Filed: December 13, 2012
    Date of Patent: November 11, 2014
    Assignee: Karisruher Insitut für Technologie
    Inventors: Alexandra Matzke, Helmut Ponta, Véronique Orian-Rousseau, Martina Tremmel
  • USE OF CD44V6 IN THE TREATMENT OF OPHTHALMIC DISEASES
    Publication number: 20120115794
    Abstract: The present invention relates to the use of peptide compounds for the prevention and/or treatment of ophthalmic diseases. In particular, the present invention relates to a peptide compound comprising an amino acid sequence displayed by amino acids 7 to 11 of SEQ ID NO: 2 (KEQWFGNRWHEGYR) or of SEQ ID NO: 1 (KEKWFENEWQGKNP), or a functionally active derivative thereof, or a pharmaceutically acceptable salt thereof, for use in the prevention and/or treatmend of an ophthalmic disease in an individual. While SEQ ID NO: 2 is a part of the human CD44v6, SEQ ID NO: 1 is a part of the rat CD44v6.
    Type: Application
    Filed: June 11, 2010
    Publication date: May 10, 2012
    Applicant: KARLSRUHER INSTITUT FÜR TECHNOLOGIE
    Inventors: Alexandra Matzke, Helmut Ponta, Véronique Orian-Rousseau, Martina Tremmel
  • CD44V6 peptides as inhibitors of bacterial infections
    Publication number: 20100305026
    Abstract: The present invention relates to the use of peptide compounds for the prevention and/or treatment of a bacterial infection.
    Type: Application
    Filed: February 16, 2010
    Publication date: December 2, 2010
    Applicant: Karlsruher Institut fur Technologie
    Inventors: Christian Jung, Véronique Orian-Rousseau, Alexandra Matzke, Helmut Ponta
  • Method for Identifying compounds for suppressing metastasizing tumor cells
    Publication number: 20060166287
    Abstract: The present invention relates to a method for identifying compounds which suppress and/or delay the development of invasive or metastasizing tumor cells of the colon, of the pancreas, of the ovaries or of the thyroid.
    Type: Application
    Filed: May 30, 2003
    Publication date: July 27, 2006
    Inventors: Helmut Ponta, Peter Herrlich, Chen Linfeng, Veronique Orian-Rousseau